endangering patients,” said the FTC's Chair, Lina Khan. “Our inquiry requests information on the factors driving these shortages and scrutinises the practices of opaque drug middlemen.” ...

The FTC this week halted a lawsuit against the country’s largest drug middlemen, which negotiate drug prices for employers and insurers. The FTC said it needs to pause the litigation because its ...

The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a "perverse drug rebate system" that it claims artificially inflated the prices ...

In court filings this week, the FTC said the case will be put on ... Optum and Express Scripts. PBMs act as middlemen between drug companies and consumers. They negotiate volume discounts and ...

The FTC sued Cigna-owned Express Scripts, CVS-owned Caremark and UnitedHealth-owned Optum Rx in September, arguing that the drug middlemen prefer more expensive insulin products because they ...

a win for the antitrust and consumer protection agency in its long-running conflict with drug benefits middlemen. “The law is clear: Complying with our orders is mandatory,” FTC Chair Andrew ...

CVS has warned it could close two dozens pharmacies in the state. CVS Caremark, other drug middlemen, blasted by FTC Auchincloss bill targets PBMs, gathers bipartisan support Auchincloss bill ...